A 32-year-old man from rural Maharashtra presents with a 3-week history of cough, low-grade fever, and night sweats. Chest X-ray shows a cavitary lesion in the right upper lobe with surrounding consolidation. Sputum smear microscopy is positive for acid-fast bacilli. What is the most appropriate next step in management?

Explanation

## Clinical Context This patient has microbiologically confirmed pulmonary tuberculosis (smear-positive) with classic radiological features (cavitary lesion in upper lobe). The clinical diagnosis is established. ## Next Step Rationale **Key Point:** Once TB is microbiologically confirmed, the immediate priority is to: 1. Obtain baseline investigations (LFTs, renal function) to assess drug tolerance 2. Send sputum for drug susceptibility testing (DST) to guide therapy regimen 3. Initiate standard first-line ATT without delay **High-Yield:** In India (RNTCP guidelines), smear-positive TB is treated as drug-susceptible TB until DST results prove otherwise. ATT must begin within 1–2 weeks of diagnosis to prevent disease progression and reduce infectivity. ## Why This Is Correct Option 2 combines the essential pre-treatment workup (DST + LFTs) with timely initiation of therapy. DST is critical because: - It confirms drug susceptibility and prevents inappropriate regimen escalation - It guides duration and composition of therapy - Baseline LFTs detect hepatic impairment that may necessitate dose adjustment or monitoring frequency ATT should not be delayed while awaiting DST results; standard HRZE (Isoniazid, Rifampicin, Pyrazinamide, Ethambutol) is started empirically in smear-positive cases. ## Diagnostic Certainty **Clinical Pearl:** Smear-positive sputum in a patient with compatible clinical and radiological findings is sufficient for TB diagnosis. No additional imaging (CT) is needed to confirm diagnosis or initiate therapy. CT is reserved for: - Assessing complications (bronchial stenosis, bronchopleural fistula) - Evaluating atypical presentations - Research or follow-up of residual lesions ## Treatment Initiation Timeline | Step | Timing | |------|--------| | Smear microscopy + clinical diagnosis | Day 0 | | Baseline LFTs, renal function, DST sent | Day 0–1 | | ATT started (standard HRZE) | Day 1–3 | | DST results available | 2–4 weeks | | Regimen adjustment if needed | Based on DST | **Mnemonic:** **DOTS** — Directly Observed Therapy, Short-course. While DOT is essential for treatment adherence, it is implemented *during* therapy, not as a prerequisite before starting drugs.